Literature DB >> 21673618

Hybrid grafting using bone marrow aspirate combined with porous β-tricalcium phosphate and trephine bone for lumbar posterolateral spinal fusion: a prospective, comparative study versus local bone grafting.

Tsuyoshi Yamada1, Toshitaka Yoshii, Shinichi Sotome, Masato Yuasa, Tsuyoshi Kato, Yoshiyasu Arai, Shigenori Kawabata, Shoji Tomizawa, Kyohei Sakaki, Takashi Hirai, Kenichi Shinomiya, Atsushi Okawa.   

Abstract

STUDY
DESIGN: A prospective, comparative study.
OBJECTIVE: We developed a hybrid graft (HBG) of porous β-tricalcium phosphate ceramics/percutaneously harvested bone sticks/autologous bone marrow aspirate for lumbar posterolateral fusion (PLF). The aim of this study was to investigate the efficacy of the HBG as a substitute for conventional corticocancellous iliac autografts. SUMMARY OF BACKGROUND DATA: Iliac crest bone graft (ICBG) has been traditionally used as the golden standard for lumbar spinal fusion. The significant complication rate associated with harvesting corticocancellous ICBG, however, has encouraged development of alternative graft substitutes.
METHODS: From September 2005, 61 consecutive patients underwent decompressive laminotomy and 1-level instrumented PLF. Each patient in this study had the constructs of the HBG placed on 1 side of the intertransverse process gutter. An autologous local bone graft (LBG) harvested during decompressive laminotomy was placed on the other side as a control. Radiographic evaluation was performed at 6 months, 1 year after surgery, and subsequently on an annual basis. The fusion statuses on either side of vertebra were compared.
RESULTS: The flexion-extension motion in the dynamic x-rays at the target level decreased over time. Only 1 case exhibited over 5° of angular motion 2 years after surgery. In the evaluation of fusion status, the fusion rate for the HBG side (68.9% at 6 months, 83.6% at 1 year, 93.5% at 2 years) was higher than that for the LBG side (49.2% at 6 months, 75.4% at 1 year, 89.1% at 2 years) with a significant difference at 6 months after surgery. No significant complications at the donor site were found postoperatively.
CONCLUSION: The HBG promoted posterolateral spinal fusion without significant donor site morbidity. Because of its efficacy and safety, this hybrid construct seems promising as an alternative to conventional iliac bone grafts for lumbar spinal fusion.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21673618     DOI: 10.1097/BRS.0b013e3182269d64

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  18 in total

1.  Bone substitutes and expanders in Spine Surgery: A review of their fusion efficacies.

Authors:  Abhijeet Kadam; Paul W Millhouse; Christopher K Kepler; Kris E Radcliff; Michael G Fehlings; Michael E Janssen; Rick C Sasso; James J Benedict; Alexander R Vaccaro
Journal:  Int J Spine Surg       Date:  2016-09-22

Review 2.  The Use of Adipose Tissue-Derived Progenitors in Bone Tissue Engineering - a Review.

Authors:  Indranil Bhattacharya; Chafik Ghayor; Franz E Weber
Journal:  Transfus Med Hemother       Date:  2016-09-15       Impact factor: 3.747

3.  Human mesenchymal stem cells and biomaterials interaction: a promising synergy to improve spine fusion.

Authors:  G Barbanti Brodano; E Mazzoni; M Tognon; C Griffoni; M Manfrini
Journal:  Eur Spine J       Date:  2012-03-16       Impact factor: 3.134

4.  Multipotential stromal cell abundance in cellular bone allograft: comparison with fresh age-matched iliac crest bone and bone marrow aspirate.

Authors:  Thomas G Baboolal; Sally A Boxall; Yasser M El-Sherbiny; Timothy A Moseley; Richard J Cuthbert; Peter V Giannoudis; Dennis McGonagle; Elena Jones
Journal:  Regen Med       Date:  2014-03-12       Impact factor: 3.806

5.  Fusion rate and clinical outcome in anterior lumbar interbody fusion with beta-tricalcium phosphate and bone marrow aspirate as a bone graft substitute. A prospective clinical study in fifty patients.

Authors:  Ricarda Lechner; David Putzer; Michael Liebensteiner; Christian Bach; Martin Thaler
Journal:  Int Orthop       Date:  2016-10-21       Impact factor: 3.075

6.  Comparison of a calcium phosphate bone substitute with recombinant human bone morphogenetic protein-2: a prospective study of fusion rates, clinical outcomes and complications with 24-month follow-up.

Authors:  Rhiannon M Parker; Gregory M Malham
Journal:  Eur Spine J       Date:  2016-12-27       Impact factor: 3.134

7.  The use of beta-tricalcium phosphate and bone marrow aspirate as a bone graft substitute in posterior lumbar interbody fusion.

Authors:  Martin Thaler; Ricarda Lechner; Michaela Gstöttner; Conrad Kobel; Christian Bach
Journal:  Eur Spine J       Date:  2012-10-17       Impact factor: 3.134

8.  Comparison of outcomes and safety of using hydroxyapatite granules as a substitute for autograft in cervical cages for anterior cervical discectomy and interbody fusion.

Authors:  Hosein Mashhadinezhad; Fariborz Samini; Reza Zare
Journal:  Arch Bone Jt Surg       Date:  2014-03-15

Review 9.  Improving the clinical evidence of bone graft substitute technology in lumbar spine surgery.

Authors:  Wellington K Hsu; M S Nickoli; J C Wang; J R Lieberman; H S An; S T Yoon; J A Youssef; D S Brodke; C M McCullough
Journal:  Global Spine J       Date:  2012-10-09

Review 10.  Bone Tissue Engineering.

Authors:  Cameron R M Black; Vitali Goriainov; David Gibbs; Janos Kanczler; Rahul S Tare; Richard O C Oreffo
Journal:  Curr Mol Biol Rep       Date:  2015-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.